# Multicenter Trial For Patients With Acute Crohn's Disease

> **NCT00035503** · PHASE2 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.**

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** etiprednol dicloacetate

## Key facts

- **NCT ID:** NCT00035503
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-31
- **Primary completion:** 2004-01-31
- **Final completion:** 2004-01-31
- **Target enrollment:** — (—)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035503, "Multicenter Trial For Patients With Acute Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00035503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*